Akoustis Technologies Inc reports results for the quarter ended in December - Earnings Summary

Aktis Oncology

31/01/2022 12:47

* Akoustis Technologies Inc  AKTS.OQ  reported a quarterly
adjusted loss of 23 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for a loss of 20 cents per share.
    * Revenue rose 180.7% to $3.67 million from a year ago; 
analysts
expected $3.78 million. 
    * Akoustis Technologies Inc's reported EPS for the quarter
was a
loss of 29 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Akoustis Technologies Inc shares had fallen by 24.4% this
quarter.
    * The company reported a quarterly loss of $15.25 million.
    * Wall Street's median 12-month price target for Akoustis
Technologies Inc is $14.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated January 31 at 12:47 p.m.
 ​All figures in US dollars unless otherwise stated